Novorapid Penfill 100iu 3ml, containing Insulin Aspart, is a fast-acting insulin used to manage blood sugar levels in individuals with type 1 and type 2 diabetes mellitus. This medication helps lower blood sugar spikes after meals, which is crucial for preventing long-term complications associated with diabetes.

Typically, Novorapid Penfill 100iu 3ml is prescribed alongside a longer-acting insulin or other antidiabetic medicines. Your doctor or nurse will instruct you on the proper technique for subcutaneous injection. It should be administered at the beginning of a meal or within 20 minutes after starting to eat. Consistent blood sugar monitoring and sharing your results with your doctor are vital to ensure the correct dosage for your needs.

Important safety information: Do not use Novorapid Penfill 100iu 3ml if your blood sugar levels are already low (hypoglycemia). Inform your doctor about any history of kidney, liver, or heart conditions before starting this treatment. Pregnant or breastfeeding individuals should also consult their doctor, as dosage adjustments may be necessary. Never stop taking this medication without your doctor's guidance. This treatment is part of a comprehensive diabetes management plan that includes a healthy diet, regular exercise, and weight management as advised by your doctor.

Common side effects associated with Novorapid Penfill 100iu 3ml include low blood sugar (hypoglycemia), headache, nasopharyngitis, and upper respiratory tract infection. To help prevent hypoglycemia, always inject the prescribed dose, eat regular meals, and monitor your blood sugar levels diligently. Excessive alcohol consumption can also significantly lower blood sugar. Other possible side effects include injection site reactions like redness, swelling, or hard lumps (lipodystrophy). Some individuals may experience weight gain while on insulin therapy.